Biomarker assessment and molecular testing for prognostication in breast cancer

Histopathology
Zuzana Kos, David J Dabbs

Abstract

Current treatment of breast cancer incorporates clinical, pathological and molecular data. Oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) define prognosis and identify tumours for targeted therapy, and remain the sole established single-molecule biomarkers defining the minimum breast cancer pathology data set. Ki67 remains one of the most promising yet controversial biomarkers in breast cancer, implemented routinely in some, but not all, pathology departments. Beyond the single-molecule biomarkers, a host of multigene expression tests have been developed to interrogate the driver pathways and biology of individual breast cancers to predict clinical outcome more accurately. A minority of these assays have entered into clinical practice. This review focuses on the established biomarkers of ER, PR and HER2, the controversial but clinically implemented biomarker Ki67 and the currently marketed gene expression signatures.

References

Jan 1, 1973·The Journal of Clinical Investigation·W L McGuire
Sep 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G LeclercqH J Tagnon
Aug 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S Munakata, J B Hendricks
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Apr 18, 2003·The International Journal of Biological Markers·E BiganzoliE Marubini
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valerie-Jeanne BardouGary M Clark
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco ColleoniAron Goldhirsch
Dec 14, 2004·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Feb 16, 2006·Journal of the National Cancer Institute·Christos SotiriouMauro Delorenzi
Feb 25, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DowsettM Baum
May 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soonmyung PaikNorman Wolmark
Jun 2, 2006·Breast Cancer Research : BCR·Laurel A HabelCharles P Quesenberry
Sep 7, 2006·Journal of the National Cancer Institute·Marc BuyseUNKNOWN TRANSBIG Consortium
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Jan 18, 2007·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN IMPACT Trialists Group
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sherene LoiChristos Sotiriou
Apr 5, 2007·The Oncologist·John P A Ioannidis
Jun 29, 2007·Journal of the National Cancer Institute·William J M HrusheskyRomano Demicheli
Jul 7, 2007·Physiological Reviews·Nina HeldringJan-Ake Gustafsson
Aug 8, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E SmithMitch Dowsett
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Jan 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marta GuixCarlos L Arteaga
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leen De MaeyerPatrick Neven
Feb 9, 2008·Cellular and Molecular Life Sciences : CMLS·M J Wieduwilt, M M Moasser
Feb 19, 2008·Nature Biotechnology·Gary K GeissKrassen Dimitrov
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiao-Jun MaDennis Sgroi

❮ Previous
Next ❯

Citations

May 9, 2016·The Journal of Allergy and Clinical Immunology·Chrysanthi SkevakiCatherine A Thornton
Feb 22, 2018·International Journal of Molecular Sciences·Marcella Regina CardosoSophie Françoise Mauricette Derchain
Sep 11, 2017·Journal of Cancer Research and Clinical Oncology·Adele Caldarella, Alessandro Barchielli
Jul 25, 2017·Molecular Nutrition & Food Research·Stefanie JaskulskiJenny Chang-Claude
Nov 16, 2018·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Luhong HanYuanting Gu
Oct 26, 2018·Applied Immunohistochemistry & Molecular Morphology : AIMM·Satu LuhtalaJorma Isola
Mar 5, 2020·Journal of Internal Medicine·B AcsJ Hartman
Sep 6, 2018·Laboratory Investigation; a Journal of Technical Methods and Pathology·Balazs AcsDavid L Rimm
Jun 24, 2020·Breast Cancer Research and Treatment·Stephanie RobertsonJohan Hartman
Aug 22, 2017·The Journal of Clinical Investigation·Nicholas A TaylorJonathan S Serody
Sep 10, 2017·Genes & Development·Ruba HalaouiLuke McCaffrey
Jul 3, 2019·Breast Cancer : Basic and Clinical Research·Elizabeth BakerPudupalayam Bhaskar
May 11, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Joohee LeeKyung-Han Lee
Sep 8, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenBent Ejlertsen
Aug 29, 2021·The Journal of Molecular Diagnostics : JMD·Lulu SunChieh-Yu Lin
May 30, 2019·Acta Cytologica·Francisco Beca, Fernando C Schmitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.